Lymphoma
📧 Sign up to get email alerts when something new happens for Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-01-09Clinical Trial Update: Image-guided Lymphadanectomy in AMIGO [NA]
The clinical trial NCT03283423, titled 'Image-guided Lymphadanectomy in AMIGO' and sponsored by Brigham and Women's Hospital, has been termi…
-
CLINICAL_TRIALS trial_result · 2026-01-08Clinical Trial Update: Strength Training Exercises to Minimise Late Effects of Childhood Leukaemia or Lymphoma Among Adolescents [NA]
This completed clinical trial investigates strength training to minimize late effects in adolescents who survived childhood leukemia or lymp…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel [EARLY_Phase 1]
An early Phase 1 trial is evaluating intrathecal dexamethasone and simvastatin to prevent neurotoxicity after axicabtagene ciloleucel therap…
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: An Intervention to Help Patients and Caregivers Manage Stress and Improve Communication Skills When Talking About Cancer [NA]
This clinical trial update describes an intervention to help patients and caregivers manage stress and improve communication about cancer, w…
-
CLINICAL_TRIALS withdrawal · 2026-01-06Clinical Trial Update: Immune Reconstitution Monitoring and Pneumococcal Vaccination in Patients Treated With CAR-T Cells [Phase 1, Phase 2]
A Phase 1/Phase 2 study evaluating immune reconstitution monitoring and pneumococcal vaccination in patients treated with CAR-T cells has be…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-06Clinical Trial Update: Clinical Cohort of Lymphoma Patients in Malawi
UNC Lineberger Comprehensive Cancer Center is recruiting a clinical cohort of lymphoma patients in Malawi (NCT02835911).
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: Study of ZG005 in Combination With Gecacitinib in Patients With Relapsed or Refractory Lymphoma [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial is evaluating ZG005 in combination with Gecacitinib in patients with relapsed or refractory lymphoma. The s…
-
CLINICAL_TRIALS research · 2026-01-05Clinical Trial Update: A Clinical Study of Allogenic CD19-CAR-T in the Treatment of R/R B-Cell Hematologic Malignancies [Phase 1]
Phase 1 trial update evaluating allogeneic CD19-CAR-T cells for relapsed/refractory B-cell hematologic malignancies, with recruitment not ye…
-
CLINICAL_TRIALS trial_result · 2026-01-02Clinical Trial Update: Study of the Angiogenesis by PET/CT in Patients With Lymphoma [Phase 2]
This update notes the completion of a Phase 2 clinical trial evaluating angiogenesis assessment by PET/CT imaging in patients with lymphoma.
-
CLINICAL_TRIALS research · 2026-01-02Clinical Trial Update: GSL Synthetase Inhibitor Eliglustat Combined With CD30 Target Immunotherapy for the Treatment of of CD30+ Lymphoma [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial from Chinese PLA General Hospital is evaluating eliglustat in combination with a CD30-targeted immunotherap…
-
CLINICAL_TRIALS research · 2025-12-31Clinical Trial Update: A Study of Mosunetuzumab Alone or With Zanubrutinib in People With Follicular Lymphoma [Phase 2]
A Phase 2 clinical trial is evaluating mosunetuzumab alone or in combination with zanubrutinib in people with follicular lymphoma and other …
-
CLINICAL_TRIALS research · 2025-12-30Clinical Trial Update: A Clinical Study Evaluating the Safety and Efficacy of GT719 Universal Cell Injection in Adult Participants With Relapsed/Refractory CD19-positive B-cell Malignant Hematological Tumors [EARLY_Phase 1]
This document provides an update on an early-phase clinical trial evaluating the safety and efficacy of GT719 Universal Cell Injection in ad…
-
CLINICAL_TRIALS trial_result · 2025-12-26Clinical Trial Update: A Study of LY3039478 in Participants With Advanced Cancer [Phase 1]
Phase 1 trial of LY3039478 in participants with advanced cancer completed; results have been posted.
-
CLINICAL_TRIALS research · 2025-12-26Clinical Trial Update: Reduced-Dose Apixaban and Rivaroxaban Versus Low-Molecular-Weight Heparin in Patients With Hematologic Malignancies [NA]
This clinical trial compares reduced-dose apixaban and rivaroxaban against low-molecular-weight heparin for venous thromboembolism managemen…
-
CLINICAL_TRIALS research · 2025-12-24Clinical Trial Update: A Study of Brentuximab Vedotin in Adults With CD30-positive Lymphoma
This update reports on a clinical trial of brentuximab vedotin in adults with CD30-positive lymphoma and indicates the study is currently ac…
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: xDRIVE for Florida-based Cancer Patients [NA]
A Florida-based clinical trial for a cancer therapy named xDRIVE is currently recruiting, sponsored by First Ascent Biomedical Inc.
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: PTCy + Sirolimus/VIC-1911 as GVHD Prophylaxis in Myeloablative PBSC Transplantation [Phase 1, Phase 2]
Phase 1/2 trial evaluating GVHD prophylaxis with post-transplant cyclophosphamide plus sirolimus and VIC-1911 in myeloablative peripheral bl…
-
CLINICAL_TRIALS research · 2025-12-18Clinical Trial Update: Bone Marrow Grafting for Leukemia and Lymphoma
Stanford University is conducting a bone marrow grafting trial for leukemia and lymphoma, with enrollment by invitation.
-
CLINICAL_TRIALS research · 2025-12-17Clinical Trial Update: Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors [Phase 1]
Phase I clinical trial update evaluating dose, pharmacokinetics, and safety of Lutetium-177-edotreotide therapy in pediatric participants wi…
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Shanghai Lymphoma Clinical Cohort
This clinical trial update reports a Shanghai-based lymphoma cohort study sponsored by Ruijin Hospital that is not yet recruiting.
-
CLINICAL_TRIALS research · 2025-12-16Clinical Trial Update: Precision Physical Exercise for Personalized Onco-Hematology. [NA]
An update on a clinical trial evaluating precision physical exercise for personalized management in onco-hematology, spanning hematologic ca…
-
CLINICAL_TRIALS research · 2025-12-15Clinical Trial Update: Application of Telemedicine to the Management of Aggressive Lymphomas [NA]
This update reports on a completed clinical trial evaluating the use of telemedicine in managing patients with aggressive lymphomas.
-
CLINICAL_TRIALS trial_result · 2025-12-15Clinical Trial Update: A Feasibility and Safety Study of Dual Specificity CD19 and CD22 CAR-T Cell Immunotherapy for CD19+CD22+ Leukemia [Phase 1]
A Phase 1 feasibility and safety study of dual CD19/CD22 CAR-T cell therapy for CD19+CD22+ leukemia, with the trial currently active but not…
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: Adaptive Bridging RT in R/R B-cell Lymphoma (Pre-CAR T) [NA]
Clinical trial update on adaptive bridging radiotherapy for relapsed/refractory B-cell lymphomas prior to CAR-T therapy; the study status is…
-
CLINICAL_TRIALS research · 2025-12-08Clinical Trial Update: Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma [Phase 1]
Phase 1 clinical trial update of anti-CD19 CAR-T cells with an inducible caspase-9 safety switch for B-cell lymphoma, currently active but n…